国产99久久久国产精品潘金莲,,,

GDMV star enterprise- Baisheng Biotechnology (Guangzhou) , as a professional pathological equipment and reagent supplier, in order to cooperate with the national measures to combat new coronary pneumonia, resume work and put into production ahead of schedule, and actively prepare antibodies required for pathological research of new coronary pneumonia Reagents are willing to provide HLA-DR antibodies and CD38 antibodies for free to scientific research institutes and hospitals nationwide that conduct related pathological research. According to the research progress of pathological anatomy, relevant reagents will be prepared as soon as possible.

GDMV Nansha Incubator actively responds to the requirements of relevant government documents at all levels on epidemic prevention and control work, implements various prevention and control measures, spares no effort to ensure the health and safety of enterprises and employees in the incubator, and makes relevant arrangements for the resumption of work and production, and to help enterprises resume work and production safely and efficiently.

疫情就是命令，防控就是責(zé)任。新型冠狀病毒感染的肺炎疫情牽動(dòng)著所有人的心。一方有難，八方支援，面對(duì)來(lái)勢(shì)洶洶的疫情，廣東醫(yī)谷園區(qū)企業(yè)快速響應(yīng)，發(fā)揮專(zhuān)長(zhǎng)，積極投入這場(chǎng)疫情防控阻擊戰(zhàn)。

In order to deeply understand the development status of enterprises in GDMV and solve the problems encountered by the enterprises in the incubator, Zhujiang Street "Government and enterprises work together to promote development | Key Enterprise Symposium of GDMV Nansha Incubator " was successfully held in GDMV Nansha Incubator on January 7, 2020.